Identification of primary care patients at risk of nonadherence to antidepressant treatment

Patient Preference and Adherence

Volumn 2, Issue , 2009, Pages 379-386

  Åkerblad, Ann Charlotte ^a   Bengtsson, Finn ^b   Holgersson, Margareta ^c   von Knorring, Lars ^a   Ekselius, Lisa ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c IQVIA   (United States)

Author keywords

Adherence; Antidepressant; Compliance; Predictors; SSRI; Unipolar depression

Indexed keywords

EID: 80052991394     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S3511     Document Type: Article

References (44)

1. Åkerblad A. C, Bengtsson F, Ekselius L, et al. 2003. Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners. Int Clin Psychopharmacol, 18:347-54.
2. Åkerblad A. C, Bengtsson F, von Knorring L, et al. 2006. Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study. Int Clin Psychopharmacol, 21:117-24.
3. Aikens J. E, Kroenke K, Swindle RW, et al. 2005. Nine-month predictors and outcome of SSRI antidepressant continuation in primary care. Gen Hosp Psych, 27:229-36.
4. [APA] American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington DC: APA.
5. Becker M. H, Maiman LA. 1975. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care, 13:10-24.
6. Bengtsson F. 2004. Therapeutic drug monitoring of psychotropic drugs. TDM "nouveau". Ther Drug Monit, 26:145-51.
7. Brook O. H, van Hout HPJ, Stalman WAB, et al. 2006. Nontricyclic antidepressants. Predictors of nonadherence. J Clin Psychopharmacol, 26:643-7.
8. Brown C., Battista DR, Bruehlman R, et al. 2005. Beliefs about antidepressant medications in primary care patients. Med Care, 43:1203-7.
9. Bull S. A, Hu XH, Hunkeler EM, et al. 2002. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA, 18:1403-9.
10. Burke M. J, Preskorn SH. 1999. Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice. Clin Pharmacokinet, 37:147-65.
11. Cantrell C. R, Eaddy MT, Shah MB, et al. 2006. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care, 44:300-3.
12. Cohen N. L, Parikh SV, Kennedy SH. 2000. Medication compliance in mood disorders: relevance of the Health Belief Model and other determinants. Primary Care Psychiatry, 6:101-8.
13. Cohen N. L, Ross EC, Bagby RM, et al. 2004. The 5-factor model of personality and antidepressant medication compliance. Can J Psychiatry, 49:106-13.
14. Compton M. T, Rudish BE, Weiss PS, et al. 2005. Predictors of psychiatristreported treatment-compliance problems among patients in routine US psychiatric care. Psychiatry Res, 137:29-36.
15. Demyttenaere K., Enzlin P, Dewé W, et al. 2001. Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. J Clin Psychiatry, 62(Suppl 22):30-3.
16. Demyttenaere K., Van Ganse E, Gregoire J, et al. 1998. Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group. Int Clin Psychopharmacol, 13:11-7.
17. Demyttenaere K. 1997. Compliance during treatment with antidepressants. J Affect Disord, 43:27-39.
18. Demyttenaere K. 2003. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol, 13(Suppl):69-75.
19. Dolan P., Gudex C, Kind P, et al. 1996. The time trade-off method: results from a general population study. Health Econ, 5:141-54.
20. Ekselius L., Bengtsson F, von Knorring L. 2000. Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality. Int Clin Psychopharmacol, 15:273-8.
21. EuroQol Group. 1990. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy, 16:199-208.
22. Frank E., Perel JM, Mallinger AG, et al. 1992. Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression. Psychopharmacol Bull, 28:231-5.
23. Gopinath S., Katon WJ, Russo JE, et al. 2007. Clinical factors associated with relapse in primary care patients with chronic or recurrent depression. J Affect Disord, 101:57-63.
24. Gustavsson J. P, Bergman H, Edman G, et al. 2000. Swedish universities Scales of Personality (SSP): construction, internal consistency and normative data. Acta Psychiatr Scand, 102:217-25.
25. Guy W. 1976. Clinical Global Impressions. In: ECDEU Manual. US Dept of Health and Human Services. Rockville MD: NIMH. pp. 217-22.
26. Hardin J. W, Hilbe JM. 2002. Generalized Estimating Equations, Baton Rouge, FL: CRC Press.
27. Hosmer D. W, Lemeshow S. 2000. Applied Logistic Regression. Hoboken, NJ: Wiley Inc.
28. Kamali M., Kelly BD, Clarke M, et al. 2006. A prospective evaluation of adherence to medication in first episode schizophrenia. Eur Psychiatry, 21:29-33.
29. Kutcher S., Leblanc J, Maclaren C, et al. 2002. A randomized trial of a specific adherence enhancement program in sertraline-treated adults with major depressive disorder in a primary care setting. Prog Neuropsychopharmacol Biol Psychiatry, 26:591-6.
30. Lin E. H, Von Korff M, Katon W, et al. 1995. The role of the primary care physician in patients' adherence to antidepressant therapy. Medical Care, 33:67-74.
31. Lingam R., Scott J. 2002. Treatment non-adherence in affective disorders. Acta Psychiatr Scand, 105:164-72.
32. Lorenc L., Branthwaite A. 1991. Are older adults less compliant with prescribed medication than younger adults? Br J Clin Psychology, 32:485-92.
33. Mackin R. S, Areán PA. 2007. Cognitive psychiatric predictors of medical treatment adherence among older adults in primary care clinics. Int J Ger Psychiatry, 22:55-60.
34. Melfi C. A, Chawla AJ, Croghan TW, et al. 1998. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry, 55:1128-32.
35. Montgomery S., Åsberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry, 134:382-9.
36. Mundt J. C, Clarke GN, Burroughs D, et al. 2001. Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education. Depress Anxiety, 13:1-10.
37. Olfson M., Marcus SC, Tedeschi M, et al. 2006. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry, 163:101-8.
38. Osterberg L., Blaschke T. 2005. Adherence to medication. N Engl J Med, 353:487-97.
39. Ottosson H., Bodlund O, Ekselius L, et al. 1998. DSM-IV and ICD-10 Personality Disorders: A comparison of a self-report questionnaire (DIP-Q) with a structured interview. Eur Psychiatry, 13:246-53.
40. Pampallona S., Bollini P, Tibaldi G, et al. 2002. Patient adherence in the treatment of depression. Br J Psychiatry, 180:104-9.
41. Salzman C. 1995. Medication compliance in the elderly. J Clin Psychiatry, 56(Suppl 1):18-22.
42. Sirey J. A, Bruce ML, Alexopoulos GS, et al. 2001. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv, 52:1615-20.
43. Vik S. A, Maxwell CJ, Hogan DB. 2004. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother, 38:303-12.
44. Wingerson D., Sullivan M, Dager S, et al. 1993. Personality traits and early discontinuation from clinical trials in anxious patients. J Clin Psychopharmacol, 13:194-7.